Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Takabatake

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Artificial Organs|December 1, 1991
Encapsulated multicellular spheroids of rat hepatocytes produce albumin and urea in a spouted bed circulating culture systemH Takabatake, N Koide, T Tsuji
Water Science and Technology : a Journal of the International Association on Water Pollution Research|August 31, 2002
PHA (polyhydroxyalkanoate) production potential of activated sludge treating wastewaterH Takabatake, H Satoh, T Mino, et al.
Anti-Cancer Drugs|January 6, 2001
Phase I study of carboplatin, docetaxel and irinotecan with recombinant human granulocyte colony stimulating factor support in patients with advanced non-small cell lung cancerA Fujita, H Takabatake, S Tagaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 8, 1998
[Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer]A Fujita, H Takabatake, S Tagaki, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancerA Fujita, H Takabatake, S Tagaki, et al.
Immunogenetics|January 1, 1995
Idiotypic diversity and variable region gene usage by mouse anti-HLA-DQ3 mAbY Iwasaki, H Takabatake, M Monestier, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Phase I study of cisplatin, ifosfamide and CPT11 with granulocyte colony-stimulating factor support in advanced non-small cell lung cancer]A Fujita, H Takabatake, S Tagaki, et al.
Horumon to Rinsho. Clinical Endocrinology|January 1, 1976
[Experimental studies of action mechanism of LH-RF by an immunologic approach]T Makino, M Shiina, H Takabatake, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1995
[Pilot study of irinotecan in refractory small cell lung cancer]A Fujita, H Takabatake, S Tagaki, et al.
Oncology|September 6, 2000
Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancerA Fujita, H Takabatake, S Tagaki, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Artificial Organs|December 1, 1991
Encapsulated multicellular spheroids of rat hepatocytes produce albumin and urea in a spouted bed circulating culture systemH Takabatake, N Koide, T Tsuji
Water Science and Technology : a Journal of the International Association on Water Pollution Research|August 31, 2002
PHA (polyhydroxyalkanoate) production potential of activated sludge treating wastewaterH Takabatake, H Satoh, T Mino, et al.
Anti-Cancer Drugs|January 6, 2001
Phase I study of carboplatin, docetaxel and irinotecan with recombinant human granulocyte colony stimulating factor support in patients with advanced non-small cell lung cancerA Fujita, H Takabatake, S Tagaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 8, 1998
[Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer]A Fujita, H Takabatake, S Tagaki, et al.
Cancer Chemotherapy and Pharmacology|February 7, 2001
Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancerA Fujita, H Takabatake, S Tagaki, et al.
Immunogenetics|January 1, 1995
Idiotypic diversity and variable region gene usage by mouse anti-HLA-DQ3 mAbY Iwasaki, H Takabatake, M Monestier, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 1996
[Phase I study of cisplatin, ifosfamide and CPT11 with granulocyte colony-stimulating factor support in advanced non-small cell lung cancer]A Fujita, H Takabatake, S Tagaki, et al.
Horumon to Rinsho. Clinical Endocrinology|January 1, 1976
[Experimental studies of action mechanism of LH-RF by an immunologic approach]T Makino, M Shiina, H Takabatake, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1995
[Pilot study of irinotecan in refractory small cell lung cancer]A Fujita, H Takabatake, S Tagaki, et al.
Oncology|September 6, 2000
Combination of cisplatin, ifosfamide, and irinotecan with rhG-CSF support for the treatment of refractory or relapsed small-cell lung cancerA Fujita, H Takabatake, S Tagaki, et al.
Pageof 5